Also, we provide a tool to detect anti-PR1 T cells and show their enrichment in patients with CML in comparison to healthy individuals and the bone marrow environment and how their phenotype can be associated with TFR. Here, TFRC is linked to chronic myelogenous leukemia, BCR-ABL1 positive.